OUR PEOPLE
We don’t just envision the possibilities, we create them.
Founded in 2014 by two of the world’s foremost experts in synthetic biology, James Collins, PhD, and Tim Lu, MD, PhD, of the Massachusetts Institute of Technology, Synlogic is comprised of visionary scientists – pioneering biologists and genetic engineers working to transform drug discovery and treat disease in a new way.
Leadership
Realizing the promise.
We are at the cusp of a revolution in medicine. Synthetic biology is an entirely new strategy in drug development, affording us the opportunity to design selective and potent living medicines to treat disease. With a team of experienced scientists and executives at the helm, Synlogic is forging new ground to advance this approach and design novel therapeutics to treat unmet medical needs.
Board of Directors
Defying convention.
As leaders in the life sciences, our Directors share our vision for the potential of Synthetic Biotics and challenge us daily to achieve more to advance our mission. Having served at the helm of biotechnology companies and investment firms, our Directors serve as strategic partners and advisors guiding us to achieve progress for patients and the field
Founders & Advisors
Running with leaders.
We have the good fortune of calling these industry, medical and scientific leaders our trusted advisors and colleagues, working alongside our team to realize the potential of synthetic biology to do more for patients.
We don’t just envision the possibilities, we create them.
Founded in 2014 by two of the world’s foremost experts in synthetic biology, James Collins, PhD, and Tim Lu, MD, PhD, of the Massachusetts Institute of Technology, Synlogic is comprised of visionary scientists – pioneering biologists and genetic engineers working to transform drug discovery and treat disease in a new way.